France's Sanofi to invest 2 billion euros in mRNA vaccines
French pharmaceutical giant Sanofi said Tuesday that it would invest 2 billion euros ($2.4 billion) in the mRNA vaccine technology behind the pioneering Covid-19 jabs developed by rivals BioNTech-Pfizer and Moderna.
Jun 29, 2021
0
1